Howard A D, Erickson K L
Department of Cell Biology and Human Anatomy, School of Medicine, University of California, Davis 95616-8643, USA.
Cell Immunol. 1995 Aug;164(1):105-12. doi: 10.1006/cimm.1995.1148.
Platelet-activating factor (PAF) has previously been shown to stimulate intracellular signal transductional events similar to the macrophage tumoricidal activators interferon-gamma (IFN-gamma) and lipopolysaccharide (LPS). Macrophages stimulated with IFN-gamma and LPS utilize various cytolytic mediators in order to kill tumor cells. However, PAF has been shown to only induce and enhance tumor necrosis factor-alpha (TNF alpha)-mediated cytolysis by macrophages. Therefore, the purpose of this study was to determine whether PAF, in comparison with IFN-gamma and LPS, could stimulate macrophages for both TNF alpha- and non-TNF alpha-mediated tumoricidal activity. For this, the activation of macrophages for a cytolytic response was characterized by the production of TNF alpha and nitric oxide (NO2-), as well as, their ability to kill select tumor cells. PAF together with IFN-gamma stimulated macrophage secretion of NO2-. In addition, PAF enhanced IFN-gamma- and LPS-stimulated NO2- production. PAF, together with IFN-gamma, also activated macrophages for tumoricidal activity against TNF alpha-resistant tumor cells. In assays to determine the temporal sequence of activation, increased tumor cell cytolysis was observed only when macrophages were first treated with IFN-gamma. Moreover, PAF enhanced macrophage tumoricidal activity when added with LPS and IFN-gamma. With respect to TNF alpha production, macrophages activated with high concentrations of PAF stimulated significant levels of TNF alpha compared to macrophages without PAF. A similar level was observed following multiple additions of a lower concentration of PAF. Also, PAF induced macrophage cytolytic activity against a TNF alpha-sensitive tumor cell. In addition, PAF significantly enhanced LPS-induced TNF alpha production. Thus, PAF can play a modulatory role in the activation for non-TNF alpha-mediated tumoricidal activity of macrophages.
血小板活化因子(PAF)此前已被证明可刺激细胞内信号转导事件,类似于巨噬细胞杀肿瘤激活剂γ干扰素(IFN-γ)和脂多糖(LPS)。用IFN-γ和LPS刺激的巨噬细胞利用各种溶细胞介质来杀死肿瘤细胞。然而,PAF已被证明仅能诱导并增强巨噬细胞介导的肿瘤坏死因子-α(TNFα)介导的细胞溶解作用。因此,本研究的目的是确定与IFN-γ和LPS相比,PAF是否能刺激巨噬细胞产生TNFα介导和非TNFα介导的杀肿瘤活性。为此,通过TNFα和一氧化氮(NO2-)的产生以及它们杀死特定肿瘤细胞的能力来表征巨噬细胞的溶细胞反应激活情况。PAF与IFN-γ一起刺激巨噬细胞分泌NO2-。此外,PAF增强了IFN-γ和LPS刺激的NO2-产生。PAF与IFN-γ一起还激活巨噬细胞对TNFα抗性肿瘤细胞具有杀肿瘤活性。在确定激活时间顺序的试验中,仅当巨噬细胞先用IFN-γ处理时,才观察到肿瘤细胞溶解增加。此外,当与LPS和IFN-γ一起添加时,PAF增强了巨噬细胞的杀肿瘤活性。关于TNFα的产生,与未用PAF处理的巨噬细胞相比,用高浓度PAF激活的巨噬细胞刺激产生了显著水平的TNFα。多次添加较低浓度的PAF后也观察到类似水平。此外,PAF诱导巨噬细胞对TNFα敏感的肿瘤细胞具有溶细胞活性。此外,PAF显著增强了LPS诱导的TNFα产生。因此,PAF在巨噬细胞非TNFα介导的杀肿瘤活性激活中可发挥调节作用。